Moderna said on Monday its experimental influenza vaccine showed superior efficacy compared with a licensed standard-dose ...

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...

Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...

The Department of Agriculture has issued its first-ever permit to vaccinate poultry against highly pathogenic avian influenza ...

Highly pathogenic avian influenza is having a deadly effect on Michigan’s eagle population. A 2022 outbreak reduced breeding ...

RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed ...

In parallel, Guyana began weekly reporting of surveillance data to the Pan American Health Organization (PAHO)/World Health Organization (WHO) via FluNet and ...

Moderna's flu vaccine candidate, mRNA-1010, shows 26.6% efficacy in a Phase 3 trial for adults 50+. Read more here.

The inaccurate rumours refer to a study looking at excess deaths during the pandemic in the German city of Frankfurt am Main.

For those who feel taking medical advice from Robert Kennedy, Jr. is risky, consider his plan for avian flu. Suggesting we ...

Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial.   In a Phase 3 study, the ...

There is variability in the airborne transmission of HPAI, making it difficult to pinpoint contamination sources and ...